EUVIMEDEUVIMED entdecken
Kohortenstudie

L26/O-083 Male infertility and risk of cancers: a population-based cohort study in New South Wales, Australia

J. Marozzi, M. Hanly, C. Venetis, M.K. O’Bryan, R. McLachlan, G.M. Chambers

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.083 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von J. Marozzi und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Is male infertility independently associated with an increased risk of incident cancer? Summary answer Compared to fertile fathers, infertile fathers have substantially higher risks of testicular cancer and non-Hodgkin lymphoma, and modestly increased risks of all-site and colorectal cancer. What is known already Cohort studies suggest that infertile men have an increased risk of incident cancers, including all-site cancer, testicular cancer, prostate cancer, although findings are mixed. There are many potential confounders for this relationship including genetic factors (congenital conditions, shared germline genetic susceptibility), lifestyle factors (smoking, diet, cardiorespiratory fitness) and environmental factors (exposure to pollution, pesticides, heavy metals, radiation) as well as health conditions like obesity, diabetes and other endocrine disorders, heart disease, sleep apnea, substance use disorders, certain infections, autoimmune conditions and mental illness. Low cancer rates make it challenging to control for numerous confounders simultaneously using typical multivariate regression methods. Study design, size, duration Our population-based cohort included 445,564 men in New South Wales (NSW), Australia whose partner conceived between 2009 and 2016. We excluded men: diagnosed with infertility pre-2009, younger than 14 at conception, or with prior cancer. The index date was the date of infertility diagnosis for infertile fathers or the later date of conception or vasectomy for fertile fathers. We followed participants from their index date until cancer diagnosis, death, or 30 June 2024. Participants/materials, setting, methods We compared incident cancer risk between fertile and infertile fathers in NSW. We identified infertility using the Australian and New Zealand Assisted Reproduction Database, hospital and fertility-procedure records and cancer outcomes through hospital, death and NSW Cancer Registry records. We mapped confounding pathways using directed acyclic graphs and addressed measured confounders with inverse probability of treatment weighting. We estimated marginal risk ratios and differences for the average treatment effect of the treated using pseudo-observations regression. Main results and the role of chance The number of events and crude incidence rates (CIR) for all-site cancer was 13.91 per 1,000 men (6,002 events) for fertile fathers and 25.48 per 1,000 men (204 events) for infertile fathers. After adjustment, we found infertile fathers had significantly increased risk for all-site cancer adjusted Risk Ratio (aRR) = 1.18 (95% CI: 1.02—1.36, p = 0.022) and adjusted risk difference (aRD) = 3.88 cases per 1,000 men (95% CI: 0.30—7.47, p = 0.034) and testicular cancer aRR = 3.28 (95% CI: 2.16—4.98, p < 0.001); aRD = 2.29 cases per 1,000 men (95% CI: 1.01—3.58, p < 0.001). We found elevated risk for colorectal cancer aRR = 1.51 (95% CI: 1.00—2.29, p = 0.049); aRD = 1.09 cases per 1,000 men (95% CI: -0.21—2.38, p = 0.099) and non-Hodgkin lymphoma aRR = 1.95 (95% CI: 1.13—3.38, p = 0.017); aRD =0.83 cases per 1,000 men (95% CI: -0.08—1.74, p = 0.72), although the risk difference confidence intervals also included zero. We found no significant difference between fertile and infertile fathers in the risk of the following cancers: blood and lymphatic system; digestive organ; kidney; leukemia; lip, oral and pharynx; lung; melanoma; prostate; respiratory system and intrathoracic organ; thyroid and other endocrinal gland; upper gastrointestinal; and urinary tract. Limitations, reasons for caution Our cohort included fathers, excluding men unable or unwilling to have children or with limited access to reproductive care, introducing selection bias. We could not adequately adjust for several environmental and lifestyle confounders. Residual confounding may bias estimates away from the null and attenuate associations for all-site and colorectal cancer. Wider implications of the findings Male infertility may signal increased risk of testicular cancer and non-Hodgkin lymphoma, consistent with prior studies. Our study is the first to use causal methods with extensive confounding control to directly estimate risks. Fertility treatment may offer an opportunity for earlier cancer detection and intervention among men. Trial registration number No

Zitieren

APA

Marozzi, J., Hanly, M., Venetis, C., O’Bryan, M., McLachlan, R., & Chambers, G. (2026). L26/O-083 Male infertility and risk of cancers: a population-based cohort study in New South Wales, Australia. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.083

Vancouver

Marozzi J, Hanly M, Venetis C, O’Bryan M, McLachlan R, Chambers G. L26/O-083 Male infertility and risk of cancers: a population-based cohort study in New South Wales, Australia. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.083

BibTeX
@article{Marozzi2026,
  author = {Marozzi, J. and Hanly, M. and Venetis, C. and O’Bryan, M.K. and McLachlan, R. and Chambers, G.M.},
  title = {L26/O-083 Male infertility and risk of cancers: a population-based cohort study in New South Wales, Australia},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.083}
}
Kostenlos starten →